Tildacerfont

Overview

Tildacerfont (SPR001; LY2371712) is an orally active, blood-brain barrier-penetrant selective corticotropin-releasing factor type 1 ( CRF1 ) receptor antagonist. Tildacerfont selectively blocks CRF1 receptors, thereby inhibiting the release of pituitary adrenocorticotropic hormone ( ACTH ). Tildacerfont can be used in research related to congenital adrenal hyperplasia.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > CRFR

Product Information

• Catalog No.: HY-113603
• CAS No.: 1014983-00-6
• Molecular Formula: C20H26ClN5OS
• Molecular Weight: 419.97
• Purity: 98.60%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source